A clinical-stage biotechnology company focused on delivering innovative immunology therapeutics.
News
- Lilly's imlunestrant takes aim at oral SERD market | Pharmaceutical | The Pharmaletter
- ALX Oncology Sets Key Data Review: Evorpacept Breast Cancer Trial Results From SABCS 2024
... San Antonio Breast Cancer Symposium (SABCS). The event will feature Dr. Alberto J. Montero, Clinical Director of Breast Cancer Medical Oncology at ...
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...
The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer Symposium (SABCS). The poster is now ...
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research ... - PR Newswire
... San Antonio Breast Cancer Symposium being held December 10-13, at the Henry B. Gonzalez Convention Center in San Antonio, Texas. The INVINCIBLE-4 ...
- US appeals court rejects Nasdaq's diversity rules for company boards - MySA
Official Inspection Station in San Antonio is one of many companies feeling the effects of the ... biotech and industrial companies as well.